Allogeneic transplantation using CD34+ selected peripheral blood progenitor cells combined with non-mobilized donor T cells for refractory severe aplastic anaemia (Q48840457)

From Wikidata

Jump to navigation Jump to search

scientific article published on 7 February 2017

Language	Label	Description	Also known as
English	Allogeneic transplantation using CD34+ selected peripheral blood progenitor cells combined with non-mobilized donor T cells for refractory severe aplastic anaemia	scientific article published on 7 February 2017

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/28169418

Allogeneic transplantation using CD34+ selected peripheral blood progenitor cells combined with non-mobilized donor T cells for refractory severe aplastic anaemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/28169418

author name string

Enkhtsetseg Purev

1

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/28169418

Xin Tian

2

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/28169418

Georg Aue

3

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/28169418

Jeremy Pantin

4

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/28169418

Phuong Vo

5

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/28169418

Reem Shalabi

6

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/28169418

Robert N Reger

7

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/28169418

Lisa Cook

8

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/28169418

Catalina Ramos

9

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/28169418

Elena Cho

10

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/28169418

Tat'yana Worthy

11

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/28169418

Hanh Khuu

12

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/28169418

David Stroncek

13

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/28169418

Neal S Young

14

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/28169418

Richard W Childs

15

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/28169418

language of work or name

0 references

publication date

7 February 2017

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/28169418

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/28169418

176

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/28169418

6

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/28169418

950-960

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/28169418

Peripheral-blood stem cells versus bone marrow from unrelated donors

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Continuing increased risk of oral/esophageal cancer after allogeneic hematopoietic stem cell transplantation in adults in association with chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Bone marrow transplantation for acquired severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Defective stromal cell function in a mouse model of infusion-induced bone marrow failure

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Iron overload, hematopoietic cell transplantation, and graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Graft-versus-host disease: The influence of type 1 and type 2 T cell cytokines

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: the Mexican experience

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Current status of allogeneic bone marrow transplantation in acquired aplastic anemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft-versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Management of adult patients older than 40 years refractory to at least one immunosuppressive course: HLA-identical sibling HSCT using fludarabine-based conditioning

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Improved outcome of patients older than 30 years receiving HLA-identical sibling hematopoietic stem cell transplantation for severe acquired aplastic anemia using fludarabine-based conditioning: a comparison with conventional conditioning regimen

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Reduced-intensity conditioning for severe aplasia using fludarabine and CY followed by infusion of ex vivo T-cell-depleted grafts leads to excellent engraftment and absence of GVHD.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Rapid donor T-cell engraftment increases the risk of chronic graft-versus-host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromes

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuria.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Graft-versus-host reactions and disease

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

How I treat acquired aplastic anemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Horse versus rabbit antithymocyte globulin in acquired aplastic anemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Kinetics of Th1/Th2 cytokines and lymphocyte subsets to predict chronic GVHD after allo-SCT: results of a prospective study.

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Hematopoiesis in 3 dimensions: human and murine bone marrow architecture visualized by confocal microscopy

1 reference

https://api.crossref.org/works/10.1111%2FBJH.14448

21 January 2018

Early reactivation of cytomegalovirus and high risk of interstitial pneumonitis following T-depleted BMT for adults with hematological malignancies

1 reference

https://pubmed.ncbi.nlm.nih.gov/28169418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prior chemotherapy and allograft CD34+ dose impact donor engraftment following nonmyeloablative allogeneic stem cell transplantation in patients with solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/28169418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/28169418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results

1 reference

https://pubmed.ncbi.nlm.nih.gov/28169418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblings

1 reference

https://pubmed.ncbi.nlm.nih.gov/28169418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preceding immunosuppressive therapy with antithymocyte globulin and ciclosporin increases the incidence of graft rejection in children with aplastic anaemia who underwent allogeneic bone marrow transplantation from HLA-identical siblings

1 reference

https://pubmed.ncbi.nlm.nih.gov/28169418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/28169418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center

1 reference

https://pubmed.ncbi.nlm.nih.gov/28169418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hematopoietic stem cell transplantation for severe aplastic anemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/28169418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1994 Consensus Conference on Acute GVHD Grading

1 reference

https://pubmed.ncbi.nlm.nih.gov/28169418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/28169418

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/BJH.14448

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/28169418

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 February 2018

http://europepmc.org/abstract/MED/28169418

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48840457&oldid=2211880119"